Nile tilapia piscidin 4, TP4

General Information


DRACP ID  DRACP02334

Peptide Name   Nile tilapia piscidin 4, TP4

Sequence  FIHHIIGGLFSAGKAIHRLIRRRRR

Sequence Length  25

UniProt ID  L0CKG3 

PubChem CID  Not available

Origin  Oreochromis niloticus

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma ~80% Killing=22 µg/ml MTS assay 24 h 1
RAW 264.7 Mouse leukemia Leukemia ~60% Killing=22 µg/ml MTS assay 24 h 1

Hemolytic Activity  Human erythrocytes: 100% Hemolysis=12.5 µg/ml; Tilapia erythrocytes: 100% Hemolysis=100 µg/ml

Normal (non-cancerous) Cytotoxicity  TO2: 50% Cell death=20 µg/ml; MRC-5: ~50% Cell death=18 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02334

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C135H226N50O27

Absent amino acids  CDEMNPQTVWY

Common amino acids  R

Mass  340987

Pl  13.2

Basic residues  10

Acidic residues  0

Hydrophobic residues  11

Net charge  10

Boman Index  -6561

Hydrophobicity  -12.8

Aliphatic Index  117.2

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23226256

Title  Five different piscidins from Nile tilapia, Oreochromis niloticus: analysis of their expressions and biological functions

Doi 10.1371/journal.pone.0050263

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_4199

DRACP is developed by Dr.Zheng's team.